Visterra
Visterra is a biologics research and early-stage clinical development company developing therapies for patients with immune-mediated and other hard-to-treat diseases. The company champions innovation, teamwork, and perseverance, aiming to make meaningful impacts through collaborative and high-performing teams. They utilize innovative technologies including computational, AI, and experimental research methods to develop novel therapeutics. Visterra is committed to extending and improving the lives of people with immune-mediated diseases, guided by scientific research and clinical strategies.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Investigational humanized IgG2 monoclonal antibody for IgA nephropathy
An investigational humanized IgG2 monoclonal antibody candidate being evaluated for treatment of IgA nephropathy (a chronic kidney disease).
Investigational humanized IgG2 monoclonal antibody for IgA nephropathy
An investigational humanized IgG2 monoclonal antibody candidate being evaluated for treatment of IgA nephropathy (a chronic kidney disease).
Services
Design and execution of early-stage clinical trials, including patient recruitment and clinical operations for investigational biologic candidates.
Agile preclinical development services to advance biologic candidates from discovery through regulatory-enabling studies and into early clinical testing.
Application of computational methods and artificial intelligence integrated with experimental research to support target identification and candidate selection.
Design and execution of early-stage clinical trials, including patient recruitment and clinical operations for investigational biologic candidates.
Agile preclinical development services to advance biologic candidates from discovery through regulatory-enabling studies and into early clinical testing.
Application of computational methods and artificial intelligence integrated with experimental research to support target identification and candidate selection.
Expertise Areas
- Biologics research
- Monoclonal antibody development
- Preclinical development and translational research
- Early-stage clinical development
Key Technologies
- Monoclonal antibody engineering
- Humanized IgG antibody formats
- Computational biology and AI-driven discovery
- Experimental preclinical models